Paroxysmal Sympathetic Hyperactivity in Neurocritical Children: A Pilot Study

Shipra Agrwal1, Pallavi2, Urmila Jhamb2

  • 1Department of Pediatrics, Army College of Medical Sciences, New Delhi, India.

Insights

Paroxysmal sympathetic hyperactivity (PSH) affects 9.2% of neurocritical children, leading to longer intensive care unit stays and mechanical ventilation. Early diagnosis and management are crucial for improving outcomes in these pediatric patients.

Area of Science:

  • Pediatric critical care medicine
  • Neurocritical care
  • Sympathetic nervous system disorders

Background:

  • Paroxysmal sympathetic hyperactivity (PSH) is a condition of excessive sympathetic response following acute brain injury.
  • Data on PSH in pediatric populations is limited.
  • This study aimed to determine the incidence and outcomes of PSH in children admitted to the pediatric intensive care unit (PICU).

Observation:

  • The study included 54 children (age 1 month to 12 years) admitted to a tertiary care PICU with neurocritical illnesses.
  • The diagnostic criteria for PSH by Moeller et al. were used.
  • Children declared brain dead were excluded.

Findings:

  • The incidence of PSH was 9.2% (5/54 children).
  • Children meeting all four PSH criteria experienced significantly longer mechanical ventilation durations, PICU stays, and higher PRISM III scores.
  • Children with incomplete PSH also showed prolonged ventilation and PICU stay, without a significant difference in mortality.

Implications:

  • PSH is a notable condition in children with neurological illnesses requiring PICU admission.
  • PSH is associated with increased illness severity and resource utilization.
  • Prompt diagnosis and targeted management of PSH are essential to potentially improve outcomes for critically ill children.
Abstract